![Loading...](https://link.springer.com/static/c4a417b97a76cc2980e3c25e2271af3129e08bbe/images/pdf-preview/spacer.gif)
-
Article
Open AccessXpert bladder cancer monitor to predict the need for a second TURB (MoniTURB trial)
To determine whether Xpert bladder cancer monitor, a noninvasive PCR-based biomarker test, can predict the need for 2nd transurethral resection of the bladder (TURB) better than clinical assessment. Patients s...
-
Article
Open AccessDeep learning-based classification of blue light cystoscopy imaging during transurethral resection of bladder tumors
Bladder cancer is one of the top 10 frequently occurring cancers and leads to most cancer deaths worldwide. Recently, blue light (BL) cystoscopy-based photodynamic diagnosis was introduced as a unique technolo...
-
Article
Open AccessSubtype specific expression and survival prediction of pivotal lncRNAs in muscle invasive bladder cancer
Comprehensive transcriptome expression analyses of bladder cancer revealed distinct lncRNA clusters with differential molecular and clinical characteristics. In this study, pivotal lncRNAs were assessed for th...
-
Article
Open AccessCDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making
Deletions of the cell cycle control gene CDKN2A are described as progression markers of non-muscle invasive bladder cancer and to be associated with fibroblast growth factor 3 (FGFR3) mutations. The prognostic ro...